Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
University: University of St Andrews
Sector(s): Life Sciences, Healthcare & Pharmaceuticals
Such compounds are alos prevalent in the material industry, such as ferromagnetic materials and TeflonTM Our technology allows a novel approach to the generation of stable fluorine-containing compounds which offers significant and advantageous changes to physical and pharmacokinetic properties. Additionally, it is capable of producing radiolabelled fluorinase compounds for positron emission tomography scans (PET scans) using equipment presently found in PET labs.
St Andrews University would be happy to discuss this technology transfer opportunity.
Please use the enquiry form below to contact us
Easy Access Documents:
Please enter your name.
Please enter the name of the company you work for.
Is your company an SME?
Please select the country you are in.
Please enter your email address.
Please enter your telephone number.
To help us process your enquiry faster please enter some details about the information you are interested in.
Please prove you are a human by completing this simple image recognition task.
University of Glasgow scientists have borrowed techniques employed in the semi-conductor industry to pattern the surfaces of either hard or soft materials and render these surfaces less adhesive to cells.
Scientists at the University of Glasgow have pioneered a new sensor technology, Lab-in-a-Pill, that could have major impact on the cost and effectiveness of bowel cancer treatment.
The Thermoelectric Sensor technology is a Nano-Calorimetric Sensor which measures very small changes in temperature. The IP provides a route to making the most sensitive calorimetric measurements (with a resolution of 0.1 mK).
The University of Glasgow is offering an exciting new model for the evaluation of new treatments for Parkinsons disease
Bisnaphthalimido derivatives exhibit considerable potential as cytotoxic agents for cancer therapy. We have created a number of new bisnapthalimidopropyl derivatives which feature polyamine linkers between the bisnapthalimidopropyl fragments. Compared to previous derivatives, the new compounds have ...